Skip to main content
GutCited

Curcumin therapy in inflammatory bowel disease: a pilot study.

Peter R Holt, Seymour Katz, Robert Kirshoff
Other Digestive diseases and sciences 2005 461 citations

Study Design

Study Type
Controlled Clinical Trial
Sample Size
10
Population
5 ulcerative proctitis and 5 Crohn's disease patients
Intervention
Curcumin therapy in inflammatory bowel disease: a pilot study. Curcumin (pure preparation)
Primary Outcome
Clinical improvement in UC proctitis and Crohn's
Effect Direction
Positive
Risk of Bias
High

Abstract

Curcumin, a natural compound used as a food additive, has been shown to have anti-inflammatory and antioxidant properties in cell culture and animal studies. A pure curcumin preparation was administered in an open label study to five patients with ulcerative proctitis and five with Crohn's disease. All proctitis patients improved, with reductions in concomitant medications in four, and four of five Crohn's disease patients had lowered CDAI scores and sedimentation rates. This encouraging pilot study suggests the need for double-blind placebo-controlled follow-up studies.

TL;DR

All proctitis patients improved, with reductions in concomitant medications in four, and four of five Crohn's disease patients had lowered CDAI scores and sedimentation rates, which suggests the need for double-blind placebo-controlled follow-up studies.

Used In Evidence Reviews

Similar Papers

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.